Kidney disease muscle loss study aims to uncover hidden risks
NCT ID NCT05353660
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at why people with chronic kidney disease (CKD) often lose muscle mass and strength, a condition called sarcopenia. Researchers will follow 1,000 adults with CKD to find risk factors for sarcopenia and see how it affects their health over time. The goal is to better understand this complication so doctors can prevent it and improve quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could identify key risk factors for muscle loss in kidney disease, leading to better prevention strategies and improved patient outcomes.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test any therapy. Results may not apply to all patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nanfang Hospital, Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510515, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could 15-Minute workouts recharge aging muscle cells?
- Can a new graft keep dialysis access working longer?
- Could muscle loss predict stroke recovery?
- Can a common gout pill shield hearts in kidney disease?
- Blood test could predict who faces rapid kidney decline in diabetes
- Can nerve changes explain Age-Related muscle loss?